These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 15846509)

  • 1. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.
    Yamagishi S; Nakamura K; Ueda S; Kato S; Imaizumi T
    Cell Tissue Res; 2005 Jun; 320(3):437-45. PubMed ID: 15846509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation.
    Yamagishi S; Inagaki Y; Nakamura K; Abe R; Shimizu T; Yoshimura A; Imaizumi T
    J Mol Cell Cardiol; 2004 Aug; 37(2):497-506. PubMed ID: 15276019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pigment-epithelium-derived factor (PEDF) inhibits angiotensin-II-induced vascular endothelial growth factor (VEGF) expression in MOLT-3 T cells through anti-oxidative properties.
    Yamagishi S; Matsui T; Nakamura K; Yoshida T; Shimizu K; Takegami Y; Shimizu T; Inoue H; Imaizumi T
    Microvasc Res; 2006 May; 71(3):222-6. PubMed ID: 16624340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azelnidipine, a dihydropyridine-based calcium antagonist, inhibits angiotensin II-induced oxidative stress generation and downregulation of pigment epithelium-derived factor mRNA levels in microvascular endothelial cells.
    Matsui T; Yamagishi S; Nakamura K; Kikuchi S; Inoue H
    Drugs Exp Clin Res; 2005; 31(5-6):215-9. PubMed ID: 16425978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pigment epithelium-derived factor is a pericyte mitogen secreted by microvascular endothelial cells: possible participation of angiotensin II-elicited PEDF downregulation in diabetic retinopathy.
    Yamagishi S; Matsui T; Nakamura K; Inoue H
    Int J Tissue React; 2005; 27(4):197-202. PubMed ID: 16440585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice.
    Jinnouchi Y; Yamagishi S; Matsui T; Takenaka K; Yoshida Y; Nakamura K; Ueda S; Imaizumi T
    Brain Res; 2007 Sep; 1167():92-100. PubMed ID: 17692294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
    Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
    Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine inhibits tumor necrosis factor-alpha-induced monocyte chemoattractant protein-1 overexpression by blocking NADPH oxidase-mediated reactive oxygen species generation.
    Yamagishi S; Inagaki Y; Kikuchi S
    Drugs Exp Clin Res; 2003; 29(4):147-52. PubMed ID: 15018305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
    Ide Y; Matsui T; Ishibashi Y; Takeuchi M; Yamagishi S
    Microvasc Res; 2010 Sep; 80(2):227-32. PubMed ID: 20381502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.
    Amano S; Yamagishi S; Inagaki Y; Nakamura K; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2005 Jan; 69(1-2):45-55. PubMed ID: 15797260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pravastatin counteracts angiotensin II-induced upregulation and activation of NADPH oxidase at plasma membrane of human endothelial cells.
    Alvarez E; Rodiño-Janeiro BK; Ucieda-Somoza R; González-Juanatey JR
    J Cardiovasc Pharmacol; 2010 Feb; 55(2):203-12. PubMed ID: 20010434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigment epithelium-derived factor (PEDF) blocks the interleukin-6 signaling to C-reactive protein expression in Hep3B cells by suppressing Rac-1 activation.
    Yoshida T; Yamagishi S; Nakamura K; Matsui T; Imaizumi T; Inoue H; Ueno T; Sata M
    Life Sci; 2006 Oct; 79(21):1981-7. PubMed ID: 16876827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
    J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minodronate, a nitrogen-containing bisphosphonate, inhibits advanced glycation end product-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation.
    Yamagishi S; Matsui T; Nakamura K; Takeuchi M
    Int J Tissue React; 2005; 27(4):189-95. PubMed ID: 16440584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.
    Sheikpranbabu S; Haribalaganesh R; Lee KJ; Gurunathan S
    Biochimie; 2010 Aug; 92(8):1040-51. PubMed ID: 20470857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenomedullin inhibits angiotensin II-induced oxidative stress and gene expression in rat endothelial cells.
    Yoshimoto T; Gochou N; Fukai N; Sugiyama T; Shichiri M; Hirata Y
    Hypertens Res; 2005 Feb; 28(2):165-72. PubMed ID: 16025744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin preconditioning of the heart: evidence for redox signaling.
    Das S; Engelman RM; Maulik N; Das DK
    Cell Biochem Biophys; 2006; 44(1):103-10. PubMed ID: 16456238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).
    Yamagishi S; Matsui T; Takenaka K; Nakamura K; Takeuchi M; Inoue H
    Diabetes Metab Res Rev; 2009 Mar; 25(3):266-71. PubMed ID: 19165765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigment epithelium-derived factor (PEDF) blocks angiotensin II-induced T cell proliferation by suppressing autocrine production of interleukin-2.
    Yamagishi S; Kikuchi S; Nakamura K; Matsui T; Takeuchi M; Inoue H
    Med Chem; 2006 May; 2(3):265-9. PubMed ID: 16948472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigment epithelium-derived factor (PEDF) inhibits survival and proliferation of VEGF-exposed multiple myeloma cells through its anti-oxidative properties.
    Seki R; Yamagishi S; Matsui T; Yoshida T; Torimura T; Ueno T; Sata M; Okamura T
    Biochem Biophys Res Commun; 2013 Feb; 431(4):693-7. PubMed ID: 23375814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.